ARCH BIOPARTNERS INC (ARCH.CA) Earnings History & Surprises

TSX-V:ARCHCA03938C1041

Current stock price

0.71 CAD
-0.02 (-2.74%)
Last:

ARCH.CA Earnings overview

Past quarterly earnings results for ARCH BIOPARTNERS INC (ARCH.CA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 28, 2026

Last Reported

Most Recent
Release Date
Mar 2, 2026
Period
Q1 / 2026
EPS Reported
-CA$0.03
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in CAD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2026 -0.03 - -35.75% - -100.00%
Q4 2025 -0.02 - -1.00% - 100.00%
Q3 2025 -0.02 - -44.29% 158.1K - -
Q2 2025 -0.02 - -12.22% - -100.00%
Q1 2025 -0.02 - - 117.9K - -60.46%
Q4 2024 -0.02 -0.02 0.99% -500.00% -360.7K - -118.18%
Q3 2024 -0.01 -0.02 30.69% -100.00% - -100.00%
Q2 2024 -0.02 -0.02 10.89% -20.00% 2.184M - -13.71%
Q1 2024 -0.02 - 42.29% 298.2K - -31.40%
Q4 2023 0.01 -0.02 124.75% 150.00% 1.984M - 105.62%
Q3 2023 -0.01 -0.02 65.35% - 116.37K - -
Q2 2023 -0.02 -0.02 25.74% - 2.531M - 125.32%
Q1 2023 -0.04 -0.01 -246.53% - 434.7K - -0.05%
Q4 2022 -0.01 -0.01 0.99% - 964.7K - -48.37%
Q3 2022 - - - -100.00%
Q2 2022 - - 1.124M - 5,224.64%
Q1 2022 - - 434.9K - -
Q4 2021 - - 1.869M - 2,651.84%
Q3 2021 - - 1.997M - 6,646.96%
Q2 2021 - - 21.1K - -28.72%
Q1 2021 - - - -100.00%
Q4 2020 - - 67.9K - -
Q3 2020 - - 29.6K - -
Q2 2020 - - 29.6K - -
Q1 2020 - - 26.1K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ARCH.CA EPS Q2Q GrowthARCH.CA EPS Q2Q GrowthEPS Q2Q Growth Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 0 -200 -400

Revenue Historical Q2Q growth and Acceleration

ARCH.CA Revenue Q2Q GrowthARCH.CA Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q4/25 Q1/26 0 2K 4K 6K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

ARCH BIOPARTNERS INC / ARCH.CA Earnings FAQ

What is the most recent earnings date for ARCH stock?

ARCH BIOPARTNERS INC (ARCH.CA) last reported earnings on 3/2/2026.

Can you provide information on whether ARCH BIOPARTNERS INC beat earnings estimates in the last quarter?

ARCH BIOPARTNERS INC (ARCH.CA) missed EPS estimates and missed revenue estimates in the most recent quarter.